Cart
sales@molnova.com
Complement factor D-IN-2
CAS No. 1903742-34-6
Complement factor D-IN-2( —— )
Catalog No. M28173 CAS No. 1903742-34-6
Complement factor D-IN-2 is an inhibitor of Complement factor D and reduces the excessive activation of complement factor D.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 316 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 381 | In Stock |
|
| 25MG | 673 | In Stock |
|
| 50MG | 930 | In Stock |
|
| 100MG | 1209 | In Stock |
|
| 200MG | 1637 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameComplement factor D-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionComplement factor D-IN-2 is an inhibitor of Complement factor D and reduces the excessive activation of complement factor D.
-
DescriptionComplement factor D-IN-2 is an inhibitor of Complement factor D and reduces the excessive activation of complement factor D.(In Vitro):Complement factor D-IN-2 acts on factor D to inhibit the complement cascade at the early and important point in the alternative complement pathway .
-
In VitroComplement factor D-IN-2 reduces the excessive activation of complement factor D.
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetComplement System
-
RecptorPARP1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1903742-34-6
-
Formula Weight574.43
-
Molecular FormulaC27H24BrN7O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (174.09 mM)
-
SMILESN/A
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kunzah Jamal, et al. Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective inhibitor with activity in an orthotopic, intracranial xenograft model with aberrant DNA repair. Cancer Res (2022) 82 (12_Supplement): 2609.
molnova catalog
related products
-
CP-289
CP-289 is a potent C5a receptor antagonist with IC50 of 1 μM.
-
Ravulizumab
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity, targeting complement factor 5 to block complement activation.
-
PMX 53 acetate(21963...
PMX-53 is a potent and orally active CD88 (C5aR) antagonist (IC50: 20 nM) and inhibits C5a-induced neutrophil myeloperoxidase release and chemotaxis with IC50 values of 22 nM and 75 nM, respectively.
